{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:46:58Z","timestamp":1790293618079,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271036"],"award-info":[{"award-number":["32271036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871073"],"award-info":[{"award-number":["31871073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171023"],"award-info":[{"award-number":["32171023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41386-025-02080-9","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:02:18Z","timestamp":1742230938000},"page":"1051-1062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["DRN-SNc serotonergic circuit drives stress-induced motor deficits and Parkinson\u2019s disease vulnerability"],"prefix":"10.1038","volume":"50","author":[{"given":"Yibo","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0608-5677","authenticated-orcid":false,"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8318-3046","authenticated-orcid":false,"given":"Bo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"2080_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-023-00622-7","volume":"18","author":"T Koeglsperger","year":"2023","unstructured":"Koeglsperger T, Rumpf SL, Schlie\u00dfer P, Struebing FL, Brendel M, Levin J, et al. Neuropathology of incidental Lewy body & prodromal Parkinson\u2019s disease. Mol Neurodegener. 2023;18:32.","journal-title":"Mol Neurodegener"},{"key":"2080_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7:47.","journal-title":"Nat Rev Dis Primers"},{"key":"2080_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00401-023-02597-7","volume":"146","author":"C Cappelletti","year":"2023","unstructured":"Cappelletti C, Henriksen SP, Geut H, Rozemuller AJM, van de Berg WDJ, Pihlstr\u00f8m L, et al. Transcriptomic profiling of Parkinson\u2019s disease brains reveals disease stage specific gene expression changes. Acta Neuropathol. 2023;146:227\u201344.","journal-title":"Acta Neuropathol"},{"key":"2080_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41583-022-00581-w","volume":"23","author":"S Arber","year":"2022","unstructured":"Arber S, Costa RM. Networking brainstem and basal ganglia circuits for movement. Nat Rev Neurosci. 2022;23:342\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"2080_CR5","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2017.09.051","volume":"96","author":"J P\u00e9rez-Fern\u00e1ndez","year":"2017","unstructured":"P\u00e9rez-Fern\u00e1ndez J, Kardamakis AA, Suzuki DG, Robertson B, Grillner S. Direct dopaminergic projections from the SNc modulate visuomotor transformation in the lamprey tectum. Neuron. 2017;96:910\u201324.e5.","journal-title":"Neuron"},{"key":"2080_CR6","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.cell.2015.08.014","volume":"162","author":"B Panigrahi","year":"2015","unstructured":"Panigrahi B, Martin KA, Li Y, Graves AR, Vollmer A, Olson L, et al. Dopamine is required for the neural representation and control of movement vigor. Cell. 2015;162:1418\u201330.","journal-title":"Cell"},{"key":"2080_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41593-023-01560-9","volume":"27","author":"S Washburn","year":"2024","unstructured":"Washburn S, O\u00f1ate M, Yoshida J, Vera J, Bhuvanasundaram R, Khatami L, et al. The cerebellum directly modulates the substantia nigra dopaminergic activity. Nat Neurosci. 2024;27:497\u2013513.","journal-title":"Nat Neurosci"},{"key":"2080_CR8","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41593-021-00889-3","volume":"24","author":"AK Dhawale","year":"2021","unstructured":"Dhawale AK, Wolff SBE, Ko R, \u00d6lveczky BP. The basal ganglia control the detailed kinematics of learned motor skills. Nat Neurosci. 2021;24:1256\u201369.","journal-title":"Nat Neurosci"},{"key":"2080_CR9","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/mds.28531","volume":"36","author":"R Gaurav","year":"2021","unstructured":"Gaurav R, Yahia-Cherif L, Pyatigorskaya N, Mangone G, Biondetti E, Valabr\u00e8gue R, et al. Longitudinal changes in neuromelanin MRI signal in Parkinson\u2019s disease: a progression marker. Mov Disord. 2021;36:1592\u2013602.","journal-title":"Mov Disord"},{"key":"2080_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease: mechanisms and models. Neuron. 2003;39:889\u2013909.","journal-title":"Neuron"},{"key":"2080_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT. Parkinson\u2019s disease and Parkinsonism. Am J Med. 2019;132:802\u201307.","journal-title":"Am J Med"},{"key":"2080_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson\u2019s disease. Lancet. 2024;403:283\u201392.","journal-title":"Lancet"},{"key":"2080_CR13","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","volume":"27","author":"MP Mattson","year":"2018","unstructured":"Mattson MP, Arumugam TV. Hallmarks of brain aging: adaptive and pathological modification by metabolic states. Cell Metab. 2018;27:1176\u201399.","journal-title":"Cell Metab"},{"key":"2080_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06012-6","volume":"7","author":"FJ Jiao","year":"2017","unstructured":"Jiao FJ, Wang QZ, Zhang P, Yan JG, Zhang Z, He F, et al. CDK5-mediated phosphorylation of XBP1s contributes to its nuclear translocation and activation in MPP(+)-induced Parkinson\u2019s disease model. Sci Rep. 2017;7:5622.","journal-title":"Sci Rep"},{"key":"2080_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41531-022-00311-0","volume":"8","author":"J Yan","year":"2022","unstructured":"Yan J, Zhang P, Tan J, Li M, Xu X, Shao X, et al. Cdk5 phosphorylation-induced SIRT2 nuclear translocation promotes the death of dopaminergic neurons in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8:46.","journal-title":"NPJ Parkinsons Dis"},{"key":"2080_CR16","first-page":"3709","volume":"55","author":"Q Wang","year":"2018","unstructured":"Wang Q, Jiao F, Zhang P, Yan J, Zhang Z, He F, et al. CDK5-mediated phosphorylation-dependent ubiquitination and degradation of E3 ubiquitin ligases GP78 accelerates neuronal death in Parkinson\u2019s disease. Mol Neurobiol. 2018;55:3709\u201317.","journal-title":"Mol Neurobiol"},{"key":"2080_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/mds.26488","volume":"31","author":"P Zhang","year":"2016","unstructured":"Zhang P, Shao XY, Qi GJ, Chen Q, Bu LL, Chen LJ, et al. Cdk5-dependent activation of neuronal inflammasomes in Parkinson\u2019s disease. Mov Disord. 2016;31:366\u201376.","journal-title":"Mov Disord"},{"key":"2080_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41531-020-00152-9","volume":"7","author":"A van der Heide","year":"2021","unstructured":"van der Heide A, Speckens AEM, Meinders MJ, Rosenthal LS, Bloem BR, Helmich RC. Stress and mindfulness in Parkinson\u2019s disease - a survey in 5000 patients. NPJ Parkinsons Dis. 2021;7:7.","journal-title":"NPJ Parkinsons Dis"},{"key":"2080_CR19","first-page":"1057","volume":"16","author":"H Yaribeygi","year":"2017","unstructured":"Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: a review. Excli j. 2017;16:1057\u201372.","journal-title":"Excli j"},{"key":"2080_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1152\/physrev.00041.2006","volume":"87","author":"BS McEwen","year":"2007","unstructured":"McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873\u2013904.","journal-title":"Physiol Rev"},{"key":"2080_CR21","doi-asserted-by":"crossref","unstructured":"Vaccarino V, Bremner JD. Stress and cardiovascular disease: an update. Nat Rev Cardiol. 2024;21:603\u201316.","DOI":"10.1038\/s41569-024-01024-y"},{"key":"2080_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/10253890.2018.1456526","volume":"21","author":"KR Mifsud","year":"2018","unstructured":"Mifsud KR, Reul J. Mineralocorticoid and glucocorticoid receptor-mediated control of genomic responses to stress in the brain. Stress. 2018;21:389\u2013402.","journal-title":"Stress"},{"key":"2080_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44704-6","volume":"15","author":"D Chen","year":"2024","unstructured":"Chen D, Lou Q, Song XJ, Kang F, Liu A, Zheng C, et al. Microglia govern the extinction of acute stress-induced anxiety-like behaviors in male mice. Nat Commun. 2024;15:449.","journal-title":"Nat Commun"},{"key":"2080_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/npjscilearn.2016.11","volume":"1","author":"S Vogel","year":"2016","unstructured":"Vogel S, Schwabe L. Learning and memory under stress: implications for the classroom. NPJ Sci Learn. 2016;1:16011.","journal-title":"NPJ Sci Learn"},{"key":"2080_CR25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41380-021-01224-9","volume":"27","author":"A Agorastos","year":"2022","unstructured":"Agorastos A, Chrousos GP. The neuroendocrinology of stress: the stress-related continuum of chronic disease development. Mol Psychiatry. 2022;27:502\u201313.","journal-title":"Mol Psychiatry"},{"key":"2080_CR26","doi-asserted-by":"publisher","first-page":"Fso23","DOI":"10.4155\/fso.15.21","volume":"1","author":"A Mariotti","year":"2015","unstructured":"Mariotti A. The effects of chronic stress on health: new insights into the molecular mechanisms of brain-body communication. Future Sci OA. 2015;1:Fso23.","journal-title":"Future Sci OA"},{"key":"2080_CR27","doi-asserted-by":"publisher","first-page":"H1476","DOI":"10.1152\/ajpheart.00859.2014","volume":"308","author":"S Golbidi","year":"2015","unstructured":"Golbidi S, Frisbee JC, Laher I. Chronic stress impacts the cardiovascular system: animal models and clinical outcomes. Am J Physiol Heart Circ Physiol. 2015;308:H1476\u201398.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2080_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41531-024-00692-4","volume":"10","author":"A van der Heide","year":"2024","unstructured":"van der Heide A, Dommershuijsen LJ, Puhlmann LMC, Kalisch R, Bloem BR, Speckens AEM, et al. Predictors of stress resilience in Parkinson\u2019s disease and associations with symptom progression. NPJ Parkinsons Dis. 2024;10:81.","journal-title":"NPJ Parkinsons Dis"},{"key":"2080_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.28345","volume":"36","author":"A van der Heide","year":"2021","unstructured":"van der Heide A, Meinders MJ, Speckens AEM, Peerbolte TF, Bloem BR, Helmich RC. Stress and mindfulness in Parkinson\u2019s disease: clinical effects and potential underlying mechanisms. Mov Disord. 2021;36:64\u201370.","journal-title":"Mov Disord"},{"key":"2080_CR30","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1111\/cns.14151","volume":"29","author":"H Cai","year":"2023","unstructured":"Cai H, Zhang P, Li T, Li M, Zhang L, Cui C, et al. Amygdalo-nigral circuit mediates stress-induced vulnerability to the parkinsonian toxin MPTP. CNS Neurosci Ther. 2023;29:1940\u201352.","journal-title":"CNS Neurosci Ther"},{"key":"2080_CR31","doi-asserted-by":"publisher","first-page":"28s","DOI":"10.1038\/sj.npp.1395332","volume":"21","author":"F Chaouloff","year":"1999","unstructured":"Chaouloff F, Berton O, Morm\u00e8de P. Serotonin and stress. Neuropsychopharmacology. 1999;21:28s\u201332s.","journal-title":"Neuropsychopharmacology"},{"key":"2080_CR32","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s10571-021-01064-9","volume":"42","author":"M Pourhamzeh","year":"2022","unstructured":"Pourhamzeh M, Moravej FG, Arabi M, Shahriari E, Mehrabi S, Ward R, et al. The roles of serotonin in neuropsychiatric disorders. Cell Mol Neurobiol. 2022;42:1671\u201392.","journal-title":"Cell Mol Neurobiol"},{"key":"2080_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s10020-022-00497-2","volume":"28","author":"A Quintero-Villegas","year":"2022","unstructured":"Quintero-Villegas A, Vald\u00e9s-Ferrer SI. Central nervous system effects of 5-HT(7) receptors: a potential target for neurodegenerative diseases. Mol Med. 2022;28:70.","journal-title":"Mol Med"},{"key":"2080_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0091-3057(95)02135-3","volume":"54","author":"FG Graeff","year":"1996","unstructured":"Graeff FG, Guimar\u00e3es FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 1996;54:129\u201341.","journal-title":"Pharmacol Biochem Behav"},{"key":"2080_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1113\/jphysiol.1953.sp004850","volume":"119","author":"W Feldberg","year":"1953","unstructured":"Feldberg W, Toh CC. Distribution of 5-hydroxytryptamine (serotonin, enteramine) in the wall of the digestive tract. J Physiol. 1953;119:352\u201362.","journal-title":"J Physiol"},{"key":"2080_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1734-1140(09)70132-X","volume":"61","author":"M Filip","year":"2009","unstructured":"Filip M, Bader M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol Rep. 2009;61:761\u201377.","journal-title":"Pharmacol Rep"},{"key":"2080_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pnpbp.2015.12.006","volume":"66","author":"A Chagraoui","year":"2016","unstructured":"Chagraoui A, Thibaut F, Skiba M, Thuillez C, Bourin M. 5-HT2C receptors in psychiatric disorders: a review. Prog Neuropsychopharmacol Biol Psychiatry. 2016;66:120\u201335.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2080_CR38","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/1531-8257(200011)15:6<1064::AID-MDS1002>3.0.CO;2-C","volume":"15","author":"SH Fox","year":"2000","unstructured":"Fox SH, Brotchie JM. 5-HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson\u2019s disease. Mov Disord. 2000;15:1064\u20139.","journal-title":"Mov Disord"},{"key":"2080_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0304-3940(88)90691-X","volume":"91","author":"K Ishimura","year":"1988","unstructured":"Ishimura K, Takeuchi Y, Fujiwara K, Tominaga M, Yoshioka H, Sawada T. Quantitative analysis of the distribution of serotonin-immunoreactive cell bodies in the mouse brain. Neurosci Lett. 1988;91:265\u201370.","journal-title":"Neurosci Lett"},{"key":"2080_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10503","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Zhong W, Wang D, Feng Q, Liu Z, Zhou J, et al. Serotonin neurons in the dorsal raphe nucleus encode reward signals. Nat Commun. 2016;7:10503.","journal-title":"Nat Commun"},{"key":"2080_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41593-022-01213-3","volume":"26","author":"P Salvan","year":"2023","unstructured":"Salvan P, Fonseca M, Winkler AM, Beauchamp A, Lerch JP, Johansen-Berg H. Serotonin regulation of behavior via large-scale neuromodulation of serotonin receptor networks. Nat Neurosci. 2023;26:53\u201363.","journal-title":"Nat Neurosci"},{"key":"2080_CR42","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1038\/s41380-022-01782-6","volume":"27","author":"W Guo","year":"2022","unstructured":"Guo W, Fan S, Xiao D, He C, Guan M, Xiong W. A midbrain-reticulotegmental circuit underlies exaggerated startle under fear emotions. Mol Psychiatry. 2022;27:4881\u201392.","journal-title":"Mol Psychiatry"},{"key":"2080_CR43","doi-asserted-by":"crossref","unstructured":"Yao L, Li Y, Diao Z, Di Y, Wu M, Wei C, et al. Stress controllability modulates basal activity of dopamine neurons in the substantia nigra compacta. eNeuro. 2021;8:ENEURO.0044-21.2021.","DOI":"10.1523\/ENEURO.0044-21.2021"},{"key":"2080_CR44","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neuron.2012.03.017","volume":"74","author":"M Watabe-Uchida","year":"2012","unstructured":"Watabe-Uchida M, Zhu L, Ogawa SK, Vamanrao A, Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron. 2012;74:858\u201373.","journal-title":"Neuron"},{"key":"2080_CR45","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1523\/JNEUROSCI.0760-05.2005","volume":"25","author":"JM Savitt","year":"2005","unstructured":"Savitt JM, Jang SS, Mu W, Dawson VL, Dawson TM. Bcl-x is required for proper development of the mouse substantia nigra. J Neurosci. 2005;25:6721\u20138.","journal-title":"J Neurosci"},{"key":"2080_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.crneur.2021.100013","volume":"2","author":"F Atrooz","year":"2021","unstructured":"Atrooz F, Alkadhi KA, Salim S. Understanding stress: Insights from rodent models. Curr Res Neurobiol. 2021;2:100013.","journal-title":"Curr Res Neurobiol"},{"key":"2080_CR47","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.1523\/JNEUROSCI.3905-08.2009","volume":"29","author":"L Abdallah","year":"2009","unstructured":"Abdallah L, Bonasera SJ, Hopf FW, O\u2019Dell L, Giorgetti M, Jongsma M, et al. Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. J Neurosci. 2009;29:8156\u201365.","journal-title":"J Neurosci"},{"key":"2080_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pharmthera.2015.11.009","volume":"157","author":"G Di Giovanni","year":"2016","unstructured":"Di Giovanni G, De Deurwaerd\u00e8re P. New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders. Pharmacol Ther. 2016;157:125\u201362.","journal-title":"Pharmacol Ther"},{"key":"2080_CR49","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-020-2235-7","volume":"581","author":"X Zhang","year":"2020","unstructured":"Zhang X, Lei B, Yuan Y, Zhang L, Hu L, Jin S, et al. Brain control of humoral immune responses amenable to behavioural modulation. Nature. 2020;581:204\u201308.","journal-title":"Nature"},{"key":"2080_CR50","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41380-019-0435-z","volume":"25","author":"MM Shi","year":"2020","unstructured":"Shi MM, Fan KM, Qiao YN, Xu JH, Qiu LJ, Li X, et al. Hippocampal \u00b5-opioid receptors on GABAergic neurons mediate stress-induced impairment of memory retrieval. Mol Psychiatry. 2020;25:977\u201392.","journal-title":"Mol Psychiatry"},{"key":"2080_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ibneur.2020.12.002","volume":"10","author":"K Kawakami","year":"2021","unstructured":"Kawakami K, Koga K. Acute elevated platform triggers stress induced hyperalgesia and alters glutamatergic transmission in the adult mice anterior cingulate cortex. IBRO Neurosci Rep. 2021;10:1\u20137.","journal-title":"IBRO Neurosci Rep"},{"key":"2080_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuropsychologia.2018.03.006","volume":"112","author":"RL Blakemore","year":"2018","unstructured":"Blakemore RL, MacAskill MR, Shoorangiz R, Anderson TJ. Stress-evoking emotional stimuli exaggerate deficits in motor function in Parkinson\u2019s disease. Neuropsychologia. 2018;112:66\u201376.","journal-title":"Neuropsychologia"},{"key":"2080_CR53","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbr.2006.10.032","volume":"177","author":"M Macht","year":"2007","unstructured":"Macht M, Brandstetter S, Ellgring H. Stress affects hedonic responses but not reaching-grasping in Parkinson\u2019s disease. Behav Brain Res. 2007;177:171\u20134.","journal-title":"Behav Brain Res"},{"key":"2080_CR54","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/mds.29457","volume":"38","author":"GD Scott","year":"2023","unstructured":"Scott GD, Neilson LE, Woltjer R, Quinn JF, Lim MM. Lifelong association of disorders related to military trauma with subsequent Parkinson\u2019s disease. Mov Disord. 2023;38:1483\u201392.","journal-title":"Mov Disord"},{"key":"2080_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1471-4159.2005.03342.x","volume":"95","author":"ST Kim","year":"2005","unstructured":"Kim ST, Choi JH, Chang JW, Kim SW, Hwang O. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J Neurochem. 2005;95:89\u201398.","journal-title":"J Neurochem"},{"key":"2080_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbi.2015.08.015","volume":"51","author":"S Sugama","year":"2016","unstructured":"Sugama S, Sekiyama K, Kodama T, Takamatsu Y, Takenouchi T, Hashimoto M, et al. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: possible role of chronic stress in the onset of Parkinson\u2019s disease. Brain Behav Immun. 2016;51:39\u201346.","journal-title":"Brain Behav Immun"},{"key":"2080_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/bs.pbr.2021.02.003","volume":"261","author":"HWM Steinbusch","year":"2021","unstructured":"Steinbusch HWM, Dolatkhah MA, Hopkins DA. Anatomical and neurochemical organization of the serotonergic system in the mammalian brain and in particular the involvement of the dorsal raphe nucleus in relation to neurological diseases. Prog Brain Res. 2021;261:41\u201381.","journal-title":"Prog Brain Res"},{"key":"2080_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0079-6123(08)00912-6","volume":"172","author":"KA Michelsen","year":"2008","unstructured":"Michelsen KA, Prickaerts J, Steinbusch HW. The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer\u2019s disease. Prog Brain Res. 2008;172:233\u201364.","journal-title":"Prog Brain Res"},{"key":"2080_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","volume":"151","author":"G \u0160imi\u0107","year":"2017","unstructured":"\u0160imi\u0107 G, Babi\u0107 Leko M, Wray S, Harrington CR, Delalle I, Jovanov-Milo\u0161evi\u0107 N, et al. Monoaminergic neuropathology in Alzheimer\u2019s disease. Prog Neurobiol. 2017;151:101\u201338.","journal-title":"Prog Neurobiol"},{"key":"2080_CR60","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.neuroscience.2008.12.051","volume":"159","author":"S Wang","year":"2009","unstructured":"Wang S, Zhang QJ, Liu J, Wu ZH, Wang T, Gui ZH, et al. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat. Neuroscience. 2009;159:850\u201361.","journal-title":"Neuroscience"},{"key":"2080_CR61","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mds.26144","volume":"30","author":"P Cheshire","year":"2015","unstructured":"Cheshire P, Ayton S, Bertram KL, Ling H, Li A, McLean C, et al. Serotonergic markers in Parkinson\u2019s disease and levodopa-induced dyskinesias. Mov Disord. 2015;30:796\u2013804.","journal-title":"Mov Disord"},{"key":"2080_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fncir.2014.00021","volume":"8","author":"C Miguelez","year":"2014","unstructured":"Miguelez C, Morera-Herreras T, Torrecilla M, Ruiz-Ortega JA, Ugedo L. Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson\u2019s disease. Front Neural Circuits. 2014;8:21.","journal-title":"Front Neural Circuits"},{"key":"2080_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105720","volume":"175","author":"R Li","year":"2024","unstructured":"Li R, Tang G, Yang J, Gao S, Wang Y, Wu X, et al. The avBNST(GABA)-VTA and avBNST(GABA)-DRN pathways are respectively involved in the regulation of anxiety-like behaviors in parkinsonian rats. Neurochem Int. 2024;175:105720.","journal-title":"Neurochem Int"},{"key":"2080_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jchemneu.2018.12.011","volume":"96","author":"PC Leal","year":"2019","unstructured":"Leal PC, Bispo JMM, Engelberth R, de ASKD, Meurer YR, Ribeiro AM, et al. Serotonergic dysfunction in a model of parkinsonism induced by reserpine. J Chem Neuroanat. 2019;96:73\u201378.","journal-title":"J Chem Neuroanat"},{"key":"2080_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18010-w","volume":"11","author":"WJ Zou","year":"2020","unstructured":"Zou WJ, Song YL, Wu MY, Chen XT, You QL, Yang Q, et al. A discrete serotonergic circuit regulates vulnerability to social stress. Nat Commun. 2020;11:4218.","journal-title":"Nat Commun"},{"key":"2080_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08256-w","volume":"10","author":"J Grandjean","year":"2019","unstructured":"Grandjean J, Corcoba A, Kahn MC, Upton AL, Deneris ES, Seifritz E, et al. A brain-wide functional map of the serotonergic responses to acute stress and fluoxetine. Nat Commun. 2019;10:350.","journal-title":"Nat Commun"},{"key":"2080_CR67","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083\u2013152.","journal-title":"Neuropharmacology"},{"key":"2080_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF03033481","volume":"11","author":"RM Kostrzewa","year":"2007","unstructured":"Kostrzewa RM, Huang NY, Kostrzewa JP, Nowak P, Brus R. Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment. Neurotox Res. 2007;11:41\u201350.","journal-title":"Neurotox Res"},{"key":"2080_CR69","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.biopsych.2016.06.005","volume":"81","author":"P Xu","year":"2017","unstructured":"Xu P, He Y, Cao X, Valencia-Torres L, Yan X, Saito K, et al. Activation of serotonin 2C receptors in dopamine neurons inhibits binge-like eating in mice. Biol Psychiatry. 2017;81:737\u201347.","journal-title":"Biol Psychiatry"},{"key":"2080_CR70","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1038\/s41380-018-0227-x","volume":"25","author":"EY Demireva","year":"2020","unstructured":"Demireva EY, Suri D, Morelli E, Mahadevia D, Chuhma N, Teixeira CM, et al. 5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy. Mol Psychiatry. 2020;25:3304\u201321.","journal-title":"Mol Psychiatry"},{"key":"2080_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl2675","volume":"10","author":"H Liu","year":"2024","unstructured":"Liu H, He Y, Liu H, Brouwers B, Yin N, Lawler K, et al. Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans. Sci Adv. 2024;10:eadl2675.","journal-title":"Sci Adv"},{"key":"2080_CR72","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bbr.2011.01.025","volume":"219","author":"M Creed-Carson","year":"2011","unstructured":"Creed-Carson M, Oraha A, Nobrega JN. Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats. Behav Brain Res. 2011;219:273\u20139.","journal-title":"Behav Brain Res"},{"key":"2080_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13917","volume":"237","author":"JP Fan","year":"2023","unstructured":"Fan JP, Zhang X, Han Y, Ji Y, Gu WX, Wu HC, et al. Subthalamic neurons interact with nigral dopaminergic neurons to regulate movement in mice. Acta Physiol (Oxf). 2023;237:e13917.","journal-title":"Acta Physiol (Oxf)"},{"key":"2080_CR74","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2021.02.001","volume":"44","author":"KZ Peters","year":"2021","unstructured":"Peters KZ, Cheer JF, Tonini R. Modulating the neuromodulators: dopamine, serotonin, and the endocannabinoid system. Trends Neurosci. 2021;44:464\u201377.","journal-title":"Trends Neurosci"},{"key":"2080_CR75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrn3154","volume":"13","author":"NC Spitzer","year":"2012","unstructured":"Spitzer NC. Activity-dependent neurotransmitter respecification. Nat Rev Neurosci. 2012;13:94\u2013106.","journal-title":"Nat Rev Neurosci"},{"key":"2080_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107848","volume":"162","author":"J Gao","year":"2020","unstructured":"Gao J, Nie L, Li Y, Li M. Serotonin 5-HT(2A) and 5-HT(2C) receptors regulate rat maternal behavior through distinct behavioral and neural mechanisms. Neuropharmacology. 2020;162:107848.","journal-title":"Neuropharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02080-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02080-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02080-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T09:03:28Z","timestamp":1747645408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-025-02080-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1038\/s41386-025-02080-9","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}